Plant Tissue Culture Market

According to Stratistics MRC, the Global Plant Tissue Culture Market is accounted for $519.8 million in 2023 and is expected to reach $1,045.7 million by 2030 growing at a CAGR of 10.5% during the forecast period. Plant tissue culture is a method used in experimental settings to reproduce and develop plants under carefully monitored circumstances. To create new plants, it entails the aseptic cultivation of plant tissues, cells, or organs in a nutritional media. Plant propagation, genetic improvement, the preservation of uncommon or endangered species, and the creation of disease-free plants are just a few of the many uses for this technique. Because plant tissue culture offers a controlled environment for plant manipulation and propagation, it has made a substantial contribution to improvements in plant science, horticulture, and agriculture.

According to the study titled ""Plant stem cell research is uncovering the secrets of longevity and persistent growth,"" published in The Plant Journal in September 2021, as a cosmetic product, stem cells have shown promise in reducing wrinkles in the crow's feet area of the face. 

Market Dynamics: 

Driver: 

Expansion of governmental assistance

The number of plant tissue culture laboratories has increased as a result of increased government assistance, which has also opened up new economic prospects. Additionally, it has made the industry more conducive to expansion as more farmers use tissue culture methods to generate high-quality, disease-free plants. They are advocating for the use of tissue culture methods to create genetically enhanced plants that are pest- and disease-resistant, increasing food security and yields. The market for plant tissue culture is mostly driven by government funding for the agricultural industry.

Restraint:

Lack of standardization in the production process

But since it necessitates constant testing and observation, a lack of uniformity in the production process and quality control can significantly raise production costs. This may also result in variances in the caliber of goods on the market, which might impact demand and customer confidence. A significant barrier to the expansion and growth of the plant tissue culture industry is the high cost of manufacturing, which also affects the market's affordability and accessibility for the general population. To get over this obstacle, it will be necessary to make efforts to lower manufacturing costs, enhance standardization and quality control, and raise public knowledge and education on the advantages of plant tissue culture goods.

Opportunity:

Application of plant tissue culture methods to the manufacturing of food items

Since plant tissue culture techniques enable the development of high-quality, genetically uniform crops free from pests and diseases, their application in the manufacture of plant-based food items is growing in popularity. Higher yields and more reliable quality are the outcomes, which increase customer desirability for these items. Furthermore, by using plant tissue culture techniques, fewer pesticides and fertilizers may be used, improving the environmental friendliness of these goods. Customers who care more about their environmental effect are starting to see this as a major selling factor. 

Threat:

Limited plant tissue culture production capacity

The primary obstacle facing the plant tissue industry has an impact on the dynamics of supply and demand in general. The market's potential to develop is impacted by the decreased supply of high-quality plant tissue culture products due to the restricted production capacity. Plant tissue culture items are in low supply, which frequently leads to price increases that make it difficult for farmers and producers to get them. It can also result in the importation of inferior goods, which has an impact on the quality and development rate of the plants cultivated using these items. This is expected to impede the expansion of the plant tissue culture industry.

Covid-19 Impact

Both positive and negative effects of the COVID-19 pandemic have been seen by the plant tissue culture sector. On the one hand, as people grow more aware of their health and the environment, the worldwide pandemic has increased demand for plant-based dietary items. The need for plant tissue culture methods to produce high-quality, genetically homogeneous crops have increased as a result of this. However, the epidemic has caused manufacturing and distribution delays as well as interruptions to the supply chain, all of which have hurt the market. 

The annual plants segment is expected to be the largest during the forecast period

The annual plants segment is estimated to have a lucrative growth, as a vast range of plants, including both annual species, may be grown using the flexible process of plant tissue culture. A plant is considered annual if it goes through one growth season from germination to seed production. Methods such as plant tissue culture are useful for annual plants because they provide a regulated environment in which a large number of disease-free, genetically identical plants may be produced quickly. This is especially advantageous for the businesses of decorative plants, horticulture, and agriculture. 

The multiplication segment is expected to have the highest CAGR during the forecast period

The multiplication segment is anticipated to witness the highest CAGR growth during the forecast period, because with the use of this technology, plants may be propagated quickly and effectively, yielding vast numbers of genetically identical and frequently disease-free plants. The market for plant tissue culture is highly dependent on the multiplication stage as it directly affects the productivity and volume of production. Moreover, the economic feasibility is greatly enhanced by the efficiency and success of multiplication, which makes it possible to produce large quantities of suitable plants for a variety of uses. The process of plant tissue culture multiplication is continually being improved by developments in tissue culture technology, plant physiology research, and the creation of optimal procedures is driving the growth of the market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to its critical role in satisfying the growing need for high-quality, disease-free planting material. The markets for plant tissue culture are anticipated to expand as a result of the horticulture and agriculture industries. Moreover, in North America, research institutes, academic institutions, and biotechnology businesses have been actively involved in plant tissue culture-related R&D. This involves working to save expenses, improve methods, and find new uses. The acceptance and development of plant tissue culture technologies in North America can be influenced by the regulatory landscape, which includes legislation pertaining to intellectual property, biotechnology, and the environment.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the numerous causes, such as the rising need for food and premium decorative plants, are contributing to this increase. There is a great demand for food and decorative plants in the area due to urbanization, growing income levels, and population growth. Moreover, China, India, and South Korea are among the nations in the Asia Pacific area that host some of the biggest plant tissue culture laboratories in the world. These nations have developed sophisticated plant tissue culture methods and technologies as a result of their robust agricultural sectors and quickly expanding biotechnology industries. 

Key players in the market

Some of the key players profiled in the Plant Tissue Culture Market include AgriForest Bio-Technologies, 3 Rivers Biotech , Alpha Laboratories, Caisson Laboratories, Inc, AgriStarts, Merck KGaA, Melford Laboratories, Lifesible, Labland Biotech Private Limited, Knight Hollow Nursery, HIMEDIA LABORATORIES, DP-Deroose Plants, Dark Heart Nursery, PhytoTech Laboratories, Inc., RuBi Bio LLC, Tissue-Grown Corporation, Segra International, Thomas Scientific, IribovSBW  and PhytocloneInc 

Key Developments:

In October 2023, Merck Strengthens Oncology Pipeline through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate, Agreement represents strong strategic fit that leverages the company’s internal DNA damage response expertise and in-house ADC capabilities

In October 2023, Merck Presents New MAVENCLAD® Data at the 9th Joint ECTRIMS-ACTRIMS congress in Milan, New data showed sustained reduction in neurofilament light chain (NfL) levels over two years of treatment with MAVENCLAD® (cladribine tablets) in patients with relapsing multiple sclerosis (RMS)

In January 2023, Dark Heart Announces World’s First Intrinsically Seedless Cannabis for Commercial Producers. This technology innovation means that triploid cannabis can be grown on the same scale as corn, wheat, or industrial hemp.

Plant Types Covered:
• Annual Plants
• Biennial Plants
• Perennial Plants
 
Stages Covered:
• Multiplication
• Explant Preparation & Inoculation
• Hardening

Type of Growth Containers Covered:
• Glass Bottles
• Test Tubes & Petri Dishes
• Plastic Containers

Crop Types Covered:
• Fruit Plants
• Wood Producing Plants
• Floriculture Plants
• Ornamental Plants
• Vegetable Plants
• Aquatic Plants
• Other Crop Types

Varieties Covered:
• Hybrid Variety
• Heirloom Variety
• GMO Variety

Sales Channels Covered:
• Agriculture Exhibitions
• Direct Sales
• Online

End Users Covered:
• Research
• Gardening & Decoration
• Forestry & Botanical Garden
• Farmers
• Government
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances